7 pending office actions
| App # | Title | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|
| 18248238 | METHOD FOR TREATING OX40 RELATED DISEASE | STEPHENS, AMELIA CAROLE | 1645 | Non-Final OA | Apr 06, 2023 |
| 17916275 | ANTIBODY COMPOSITION | BRISTOL, LYNN ANNE | 1643 | Non-Final OA | Sep 30, 2022 |
| 17789040 | POLYNUCLEOTIDE AND PHARMACEUTICAL COMPOSITION | RILEY, JEZIA | 1681 | Non-Final OA | Jun 24, 2022 |
| 17642485 | DCR3 VARIANT | REYNOLDS, FRED H | 1658 | Final Rejection | Mar 11, 2022 |
| 17290365 | METHOD FOR PREPARING LIQUID MEDIUM | TRAN, KHOA NHAT | 1632 | Final Rejection | Apr 30, 2021 |
| 17280403 | ANTIBODY COMPOSITION | STONEBRAKER, ALYSSA RAE | 1642 | Final Rejection | Mar 26, 2021 |
| 16608474 | OLIGONUCLEOTIDE DERIVATIVE OR SALT THEREOF | VANHORN, ABIGAIL LOUISE | 1636 | Non-Final OA | Oct 25, 2019 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial